Ratchaphruek Hospital 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ratchaphruek Hospital.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Healthcare 수익 성장	10.7%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

Recent updates

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Ratchaphruek Hospital 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SET:RPH - 애널리스트의 미래 추정치 및 과거 재무 데이터 (THB Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2024	1,148	176	287	316	N/A
3/31/2024	1,169	186	366	385	N/A
12/31/2023	1,161	184	342	361	N/A
9/30/2023	1,109	140	422	447	N/A
6/30/2023	1,071	130	388	417	N/A
3/31/2023	1,071	142	268	311	N/A
12/31/2022	1,326	286	401	484	N/A
9/30/2022	1,687	519	410	488	N/A
6/30/2022	1,828	609	379	458	N/A
3/31/2022	1,734	565	426	487	N/A
12/31/2021	1,413	403	271	291	N/A
9/30/2021	1,040	218	150	173	N/A
6/30/2021	811	93	168	189	N/A
3/31/2021	783	83	157	189	N/A
12/31/2020	799	94	132	186	N/A
9/30/2020	778	76	106	173	N/A
6/30/2020	800	83	105	186	N/A
3/31/2020	828	96	48	193	N/A
12/31/2019	817	96	24	203	N/A
9/30/2019	775	78	-81	199	N/A
6/30/2019	710	59	-225	149	N/A
3/31/2019	628	60	-356	128	N/A
12/31/2018	533	48	-565	88	N/A
9/30/2018	476	62	-575	55	N/A
6/30/2018	436	75	-573	86	N/A
3/31/2018	427	73	N/A	92	N/A
12/31/2017	413	63	N/A	85	N/A
9/30/2017	411	64	N/A	105	N/A
6/30/2017	405	60	N/A	87	N/A
3/31/2017	401	59	N/A	78	N/A
12/31/2016	410	68	N/A	86	N/A
9/30/2016	406	64	N/A	82	N/A
6/30/2016	399	59	N/A	87	N/A
3/31/2016	395	54	N/A	81	N/A
12/31/2015	382	45	N/A	81	N/A
12/31/2014	301	48	N/A	69	N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if RPH's forecast earnings growth is above the savings rate (2%).

수익 vs 시장: Insufficient data to determine if RPH's earnings are forecast to grow faster than the TH market

고성장 수익: Insufficient data to determine if RPH's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if RPH's revenue is forecast to grow faster than the TH market.

고성장 수익: Insufficient data to determine if RPH's revenue is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: Insufficient data to determine if RPH's Return on Equity is forecast to be high in 3 years time

Ratchaphruek Hospital 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 26% to ฿5.50

Consensus EPS estimates increase by 16%

Consensus revenue estimates increase by 13%

Consensus EPS estimates increase by 65%

Price target increased to ฿7.45

Consensus EPS estimates increase to ฿0.21

Recent updates

Now 20% undervalued after recent price drop

Upcoming dividend of ฿0.11 per share

First half dividend of ฿0.11 announced

Second quarter 2024 earnings released: EPS: ฿0.064 (vs ฿0.082 in 2Q 2023)

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

First quarter 2024 earnings released: EPS: ฿0.071 (vs ฿0.068 in 1Q 2023)

High number of new directors

Ratchaphruek Hospital Public Company Limited Announces Audit Committee Changes

Upcoming dividend of ฿0.19 per share

Full year 2023 earnings released: EPS: ฿0.34 (vs ฿0.53 in FY 2022)

Ratchaphruek Hospital Public Company Limited Proposes Dividend for 2023, Payable on May 15, 2024

Third quarter 2023 earnings released: EPS: ฿0.12 (vs ฿0.10 in 3Q 2022)

Upcoming dividend of ฿0.11 per share at 3.5% yield

Ratchaphruek Hospital Public Company Limited Announces Termination of Supaporn Sukhee as Deputy Accounting and Financial Director

Second quarter 2023 earnings released: EPS: ฿0.082 (vs ฿0.10 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.068 (vs ฿0.33 in 1Q 2022)

Upcoming dividend of ฿0.15 per share at 5.7% yield

Price target decreased by 26% to ฿5.50

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: ฿0.10 (vs ฿0.27 in 3Q 2021)

Upcoming dividend of ฿0.20 per share

Ratchaphruek Hospital Public Company Limited Announces Management Appointments

Second quarter 2022 earnings released: EPS: ฿0.10 (vs ฿0.026 in 2Q 2021)

Ratchaphruek Hospital Public Company Limited Announces Cash Dividend for the Operating Period from January 1, 2022, to June 30, 2022, Payable on September 1, 2022

Investor sentiment improved over the past week

Consensus EPS estimates increase by 16%

First quarter 2022 earnings: EPS exceeds analyst expectations

Consensus revenue estimates increase by 13%

Less than half of directors are independent

Upcoming dividend of ฿0.25 per share

Consensus EPS estimates increase by 65%

Now 20% undervalued

Ratchaphruek Hospital Public Company Limited Appoints Mr. Adisorn Thavornthanasarn as New Independent Director

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: EPS ฿0.27 (vs ฿0.038 in 3Q 2020)

Company Secretary. CFO & Investor Relations Chatsiam Jariyawattanagulgit has left the company

Price target increased to ฿7.45

Upcoming dividend of ฿0.05 per share

Consensus EPS estimates increase to ฿0.21

Second quarter 2021 earnings released: EPS ฿0.026 (vs ฿0.007 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.035 (vs ฿0.055 in 1Q 2020)

Upcoming dividend of ฿0.10 per share

Ratchaphruek Hospital Public Company Limited Announces Executive Appointments

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS ฿0.17 (vs ฿0.18 in FY 2019)

Ratchaphruek Hospital Public Company Limited Announces Appointment of Mr. Vorathep Rangchaikul as Director

Ratchaphruek Hospital Public Company Limited Announces the Resignation of Mr. Vanchai Wattanasapt as Director and Audit Committee

Market bids up stock over the past week

New 90-day high: ฿5.55

Third quarter 2020 earnings released: EPS ฿0.038

New 90-day high: ฿5.50

Analysts lower EPS estimates to ฿0.12

Earnings released

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견